INVO Fertility Q2 2026 revenue up 17% to $2.18M; net income $0.9M vs $3.6M loss

INVO Fertility, Inc.

2026-Q2 EPS reported -$2.48 revenue$4,190,710

Revenue $2,175,485, up 17% YoY; clinic revenue $2,167,785, up 18% from $1,832,094.
Net income $0.9M vs $(3.6)M loss; includes ~$2.5M gain on Birmingham acquisition remeasurement.
Clinic-Level Adjusted EBITDA $333K in Q2 vs $164K in Q1; $951K for FY 2025.
Adjusted EBITDA $(1.0)M vs $(0.6)M; cash $3.7M at June 30, 2026.
Birmingham clinic now wholly owned after June 2026 acquisition of remaining interests.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.